This Group aims to better understand the effects of cancer and treatment on health-related quality of life for patients across diverse population groups and cultures. Members develop and refine related questionnaires for oncology clinical trials, other well-designed research studies and clinical practice. They also collaborate with other EORTC research groups to implement studies in clinical trials. EORTC’s QLQ-C30 questionnaire which has become one of the standard tools to measure quality of life in cancer clinical trials. The core questionnaire, currently available in over 120 languages, is accompanied by more than 25 fully-validated modules, addressing disease or population-specific concerns.


Want to read in detail our scientific findings on specific tumour type?
Search through our comprehensive list of EORTC published articles to date.